Suppr超能文献

肥厚型心肌病中的运动表现。

Exercise performance in hypertrophic cardiomyopathies.

作者信息

Lösse B, Kuhn H, Loogen F, Schulte H D

出版信息

Eur Heart J. 1983 Nov;4 Suppl F:197-208. doi: 10.1093/eurheartj/4.suppl_f.197.

Abstract

Based on bicycle ergometer tests in 50 patients with hypertrophic obstructive cardiomyopathy (HOCM) and 19 patients with hypertrophic non-obstructive cardiomyopathy (HNCM) if clinical (NYHA) class I to IV, the profile of several haemodynamic parameters (heart rate, stroke volume index, cardiac index, pulmonary artery pressure) during exercise was evaluated. The following pattern was found: (1) with increasing degree of clinical symptoms, the mean values of stroke volume decrease and the mean values of pulmonary artery pressure increase; (2) stroke volume does not show the normal increase during exercise in a considerable number of patients (48% of HOCM, 26% of HNCM patients); (3) failing increase in stroke volume is in part compensated by increase in heart rate; (4) pathological increase in mean pulmonary artery pressure correlates with severity of clinical symptoms, but even a considerable number of clinically asymptomatic patients exhibit extremely pathological pressure increase; (5) there is no fundamental difference of the behaviour of the measured haemodynamic parameters between HOCM and HNCM; (6) there is marked overlapping of exercise-induced haemodynamic changes between patients of different NYHA classes of clinical impairment. Therefore, measurements of exercise haemodynamics are necessary to define clearly the degree of functional impairment in the individual patient. Based on identically performed exercise tests in 53 patients with HOCM, the clinical and haemodynamic effects of medical therapy with propranolol (n = 12) or verapamil (n = 25) and of surgical treatment (n = 21) were compared. Maximal exercise capacity was on an average not changed after propranolol but increased after verapamil and, most significantly, after surgery. This could be attributed to corresponding haemodynamic changes, especially concerning cardiac output and pulmonary artery pressure. As a whole, verapamil was clinically and haemodynamically superior to propranolol, but not as effective as surgical treatment.

摘要

基于对50例肥厚性梗阻性心肌病(HOCM)患者和19例肥厚性非梗阻性心肌病(HNCM)患者(临床纽约心脏协会(NYHA)心功能分级为I至IV级)进行的自行车测力计测试,对运动期间的几个血流动力学参数(心率、每搏量指数、心脏指数、肺动脉压)的情况进行了评估。发现了以下模式:(1)随着临床症状程度的增加,每搏量平均值下降,肺动脉压平均值升高;(2)相当数量的患者(48%的HOCM患者,26%的HNCM患者)在运动期间每搏量未呈现正常增加;(3)每搏量未能增加部分由心率增加代偿;(4)平均肺动脉压的病理性升高与临床症状严重程度相关,但即使是相当数量的临床无症状患者也表现出极度病理性的压力升高;(5)HOCM和HNCM之间所测血流动力学参数的变化情况没有根本差异;(6)不同NYHA临床损害分级的患者之间运动诱导的血流动力学变化存在明显重叠。因此,有必要进行运动血流动力学测量以明确个体患者的功能损害程度。基于对53例HOCM患者进行的相同运动测试,比较了普萘洛尔(n = 12)或维拉帕米(n = 25)药物治疗以及手术治疗(n = 21)的临床和血流动力学效果。使用普萘洛尔后最大运动能力平均未改变,但使用维拉帕米后增加,最显著的是手术后。这可归因于相应的血流动力学变化,尤其是关于心输出量和肺动脉压的变化。总体而言,维拉帕米在临床和血流动力学方面优于普萘洛尔,但不如手术治疗有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验